Ixico Regulatory News (IXI)

IXICO plc

("IXICO" or the "Company")

Notice of results

Analyst and Investor presentations

IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, announces its audited Final Results for the year ended 30 September 2021 on Tuesday 7 December 2021.

Analyst briefing

A briefing open to analysts will take place remotely via video conference call on Tuesday 7 December 2021 at 9.30am (GMT). If you would like the details of this call please contact Walbrook PR on IXICO@walbrookpr.com

Investor briefing

Giulio Cerroni, CEO, and Grant Nash, CFO, will provide a live presentation relating to the Final Results for the year ended 30 September 2021 via the Investor Meet Company platform on Tuesday 7 December 2021 at 4:30pm (GMT).

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet IXICO PLC via:

https://www.investormeetcompany.com/ixico-plc/register-investor 

Investors who already follow IXICO PLC on the Investor Meet Company platform will automatically be invited.

For further information please contact:

About IXICO

IXICO is dedicated to delivering insights in neuroscience. Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience and our goal is to be a leading proponent of artificial intelligence in medical image analysis. We will achieve this by developing and deploying breakthrough data analytics, at scale, through our remote access technology platform, to improve the return on investment in drug development and reduce risk and uncertainty in clinical trials for our pharmaceutical clients.

More information is available on www.IXICO.com and follow us on Twitter @IXICOnews